NCT06211855 is a clinical trial of doppler assesment in Idiopathic Polyhydramios Cases, sponsored by Necmettin Erbakan University.

Who is sponsoring NCT06211855?

NCT06211855 is sponsored by Necmettin Erbakan University.

What drugs are being tested in NCT06211855?

Interventions in NCT06211855: doppler assesment.

What condition does NCT06211855 study?

NCT06211855 studies Idiopathic Polyhydramios Cases.

Is NCT06211855 still recruiting?

NCT06211855 is currently completed. Last updated 18 January 2024.

Last reviewed 2024-01-18 · How we verify

NCT06211855

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cerebroplacental Ratio and Perinatal Outcomes in Mild and Moderate Idiopathic Polyhydramios Cases

Completed Last updated 18 January 2024

What this trial tests

trial testing doppler assesment in Idiopathic Polyhydramios Cases in 140 participants. Completed in 30 November 2023.

Timeline

1 January 2023

Primary endpoint
30 November 2023

30 November 2023

Quick facts

Lead sponsor	Necmettin Erbakan University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	140
Start date	1 January 2023
Primary completion	30 November 2023
Estimated completion	30 November 2023
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

doppler assesment

Conditions studied

Idiopathic Polyhydramios Cases — all drugs for Idiopathic Polyhydramios Cases →

Sponsor

Necmettin Erbakan University

Who can join

Adults 18 to 45, female only, with Idiopathic Polyhydramios Cases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the predictability of fetal Doppler parameters in terms of perinatal adverse outcomes in singleton pregnancies with mild and moderate idiopathic polyhydramnios

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Necmettin Erbakan University trials

Trials by the same sponsor.

NCT07128407 — PMT-Based Radiation Safety Training for Nurses: Randomized Controlled Trial. · NA · active not recruiting
NCT07504770 — Surgical Glove Compression to Prevent Paclitaxel Neuropathy · NA · not yet recruiting
NCT07242807 — Minimally Invasive Prostate Interventions Registry (MIST Study) · not yet recruiting
NCT07442331 — The Effect of Game-Based Learning on Identifying Cognitive Distortions and Interpersonal Communication Competence in Nur · NA · completed
NCT07396038 — INTRAOPERATIVE BLADDER INJURY ASSESSMENT IN TURBT USING BICEP · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06211855 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Necmettin Erbakan University
Last refreshed: 18 January 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06211855.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing